Myllärniemi M[au] - Search Results

Year	Number of Results
1994	1
1995	5
1996	7
1997	3
1999	4
2001	1
2005	1
2006	6
2007	6
2008	10
2009	5
2010	9
2011	5
2012	4
2013	5
2014	7
2015	5
2016	3
2017	5
2018	8
2019	6
2020	7
2021	2

1

Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events.

Bendstrup E, Wuyts W, Alfaro T, Chaudhuri N, Cornelissen R, Kreuter M, Melgaard Nielsen K, Münster AB, Myllärniemi M, Ravaglia C, Vanuytsel T, Wijsenbeek M. Bendstrup E, et al. Among authors: myllarniemi m. Respiration. 2019;97(2):173-184. doi: 10.1159/000495046. Epub 2018 Dec 13. Respiration. 2019. PMID: 30544129 Review.

2

Malignant Peritoneal Mesothelioma: Treatment Options and Survival.

Salo SAS, Ilonen I, Laaksonen S, Myllärniemi M, Salo JA, Rantanen T. Salo SAS, et al. Among authors: myllarniemi m. Anticancer Res. 2019 Feb;39(2):839-845. doi: 10.21873/anticanres.13183. Anticancer Res. 2019. PMID: 30711965

3

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry.

Kaunisto J, Salomaa ER, Hodgson U, Kaarteenaho R, Kankaanranta H, Koli K, Vahlberg T, Myllärniemi M. Kaunisto J, et al. Among authors: myllarniemi m. ERJ Open Res. 2019 Jul 8;5(3):00170-2018. doi: 10.1183/23120541.00170-2018. eCollection 2019 Jul. ERJ Open Res. 2019. PMID: 31304177 Free PMC article.

4

Histopathological features of epithelioid malignant pleural mesotheliomas in patients with extended survival.

Paajanen J, Laaksonen S, Kettunen E, Ilonen I, Vehmas T, Salo J, Räsänen J, Sutinen E, Ollila H, Mäyränpää MI, Myllärniemi M, Wolff H. Paajanen J, et al. Among authors: myllarniemi m. Hum Pathol. 2020 Apr;98:110-119. doi: 10.1016/j.humpath.2020.02.007. Epub 2020 Mar 3. Hum Pathol. 2020. PMID: 32142836 Free article.

5

Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis.

Seppälä S, Rajala K, Lehto JT, Sutinen E, Mäkitalo L, Kautiainen H, Kankaanranta H, Ainola M, Saarto T, Myllärniemi M. Seppälä S, et al. Among authors: myllarniemi m. ERJ Open Res. 2020 Oct 5;6(4):00347-2020. doi: 10.1183/23120541.00347-2020. eCollection 2020 Oct. ERJ Open Res. 2020. PMID: 33043051 Free PMC article.

6

Prognostic role of radiological peritoneal cancer index in malignant peritoneal mesothelioma: national cohort study.

Salo SAS, Lantto E, Robinson E, Myllärniemi M, Laaksonen S, Salo JA, Rantanen T, Ilonen I. Salo SAS, et al. Among authors: myllarniemi m. Sci Rep. 2020 Aug 6;10(1):13257. doi: 10.1038/s41598-020-70044-8. Sci Rep. 2020. PMID: 32764701 Free PMC article.

7

Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses.

Paajanen J, Laaksonen S, Ilonen I, Vehmas T, Mäyränpää MI, Sutinen E, Kettunen E, Salo JA, Räsänen J, Wolff H, Myllärniemi M. Paajanen J, et al. Among authors: myllarniemi m. Clin Lung Cancer. 2020 Nov;21(6):e633-e639. doi: 10.1016/j.cllc.2020.05.020. Epub 2020 May 23. Clin Lung Cancer. 2020. PMID: 32624414

8

Artificial intelligence identifies inflammation and confirms fibroblast foci as prognostic tissue biomarkers in idiopathic pulmonary fibrosis.

Mäkelä K, Mäyränpää MI, Sihvo HK, Bergman P, Sutinen E, Ollila H, Kaarteenaho R, Myllärniemi M. Mäkelä K, et al. Among authors: myllarniemi m. Hum Pathol. 2021 Jan;107:58-68. doi: 10.1016/j.humpath.2020.10.008. Epub 2020 Nov 5. Hum Pathol. 2021. PMID: 33161029 Free article.

9

Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways.

Saraswat M, Joenväärä S, Tohmola T, Sutinen E, Vartiainen V, Koli K, Myllärniemi M, Renkonen R. Saraswat M, et al. Among authors: myllarniemi m. Sci Rep. 2020 May 8;10(1):7787. doi: 10.1038/s41598-020-64759-x. Sci Rep. 2020. PMID: 32385381 Free PMC article.

10

Malignant pleural mesothelioma in Finland: regional and gender variation.

Laaksonen S, Ilonen I, Kuosma E, Sutinen E, Wolff H, Vehmas T, Husgafvel-Pursiainen K, Salo JA, Koli K, Räsänen J, Myllärniemi M. Laaksonen S, et al. Among authors: myllarniemi m. Acta Oncol. 2019 Jan;58(1):38-44. doi: 10.1080/0284186X.2018.1532599. Epub 2018 Oct 30. Acta Oncol. 2019. PMID: 30375909

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results